Dr. Vishwajeeth Pai

Boi : Dr. Vishwajeeth Pai is a Consultant Radiation Oncologist at HCG Cancer Centre, Bengaluru, with extensive experience in treating various cancers using advanced radiation therapy techniques. He is known for his precision-based treatment approach and clinical expertise.
Qualification : MBBS, MD (Internal Medicine), DM (Medical Oncology), DNB (Medical Oncology), ECMO Certification (Switzerland), Fellowship in Palliative Care
Specialities : Medical Oncology
Locations :HCG Cancer Center – KR BLR, HCG Cancer Center – DR BLR

Available for consultations at HCG Cancer Centre (KR Road), Bangalore.
Specializes in diagnosis, treatment, and management of hematological malignancies and solid tumors in adults and pediatric patients.
Primary focus: breast cancer, lung cancer, and gynecological cancers. Secondary focus: urological cancers and lymphomas.
Expert in bone marrow transplantation: autologous, allogeneic, haplo-identical, and match-unrelated donor.
Experienced in administering palliative care to improve quality of life for cancer patients.

Primary Investigator: clinical trial on chemotherapy-induced nausea and vomiting in children.
Co-Primary Investigator: DESTINY Breast-006 clinical trial.
Co-Primary Investigator: first CAR-T trial (IMN-003A00-201 Phase 2) for refractory lymphomas and acute lymphoblastic leukemias.
Upcoming trial: multiomics-based prediction for chemotherapy response in high-grade serous ovarian cancers.

Radhakrishnan V, Vishwajeeth Pai et al. Olanzapine vs Metoclopramide for breakthrough chemotherapy-induced vomiting in children – open-label, randomized phase 3 trial. Pediatr Blood Cancer. 2020;67:e2853.
Chandrashekhar K, Vishwajeeth K Pai. Painful Unidigital Clubbing – First sign of malignancy. Int J Sci Res, Vol 4, Issue 8, Aug 2015.